febrile seizures market is expected to grow at a CAGR 5.5% during the forecast period of 2017-2023

Market Research Future has a half cooked research report on the febrile seizure market.

Market Highlights

A Febrile Seizure is also known as a fever fit or febrile convulsion, characterized by high body temperature. The condition is most common in children between the ages of 6 months and 5 years. Febrile seizures occur in 2%-4% of children younger than five years old.

A number of factor such as growing public awareness, technological advancements, increasing the incidence of neurological disorders, unmet medical needs, increasing government assistance, rising healthcare expenditure, improving regulatory framework, and raising funding and reimbursement are propelling the growth of the global febrile seizures market.

However, challenges in the research and development, side-effects of treatment, the presence of misbranded and spurious drugs, and poor healthcare system in low and middle-income countries may hamper the growth of the market.

Get a sample report at https://www.marketresearchfuture.com/sample_request/5250 .

Key Players

Some of the key players in the global febrile seizures market are Sanofi, Cardinal Health, Merck, Pfizer, Johnson & Johnson, Abbott Laboratories, GlaxoSmithKline plc, Cephalon Inc., Shire, and UCB S.A, and others.

The Americas dominate the febrile seizures market owing to the rising awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.

Europe holds the second position in the febrile seizures market. It is expected that the support provided by the government bodies for research & development and improvement in reimbursement policies in the healthcare is likely to drive the European market growth.

The Asia Pacific is the fastest growing febrile seizures market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the least market share of the global market due to lack of technical knowledge and poor medical facilities.

Browse Complete Report at https://www.marketresearchfuture.com/reports/febrile-seizures-market-5250 .

The global febrile seizures market is segmented on the basis of type, diagnosis, treatment, and distribution channels.

On the basis of the type, the market is classified as simple febrile seizure and complex febrile seizure.

On the basis of the diagnosis, the market is classified as physical examination, laboratory tests, electroencephalogram (EEG), and others. The laboratory tests are further segmented into blood tests, urine tests, and lumbar puncture.

On the basis of the treatment, the market is classified as home management, antipyretic medication, and others.

On the basis of the distribution channel, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.

According to a study published in the Iranian Journal of Child Neurology in 2014, it is found that the pooled prevalence of febrile seizures in Iran was 47.9%.

Notably, growing public awareness and technological advancements are the key factors driving the febrile seizures market. Nowadays, people are becoming more aware of different types of neurological disorders. Government and other different organizations have started educating people about hygiene and diseases through seminars, and conferences. People are becoming more aware and health conscious. Thus, increasing awareness has provided a push to the growth of the market.

The prevalence rate of febrile seizures has been decreasing from childhood to adulthood, suggested by the national epidemiological survey.

Various other factors such as increasing incidence of neurological disorders, unmet medical needs, increasing government assistance, rising healthcare expenditure, improving regulatory framework, and rising funding and reimbursement are continuously contributing to the growth of the global febrile seizures market. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion, which is further followed by France with EUR 237 billion, and United Kingdom with EUR 223 billion.

More Inquire at https://www.marketresearchfuture.com/enquiry/5250 .

The Americas dominate the global febrile seizures market owing to the rising awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.

Europe holds the second position in the febrile seizures market. It is expected that the support provided by the government bodies for research & development and improvement in the reimbursement policies in the healthcare is likely to drive the market of the European region.

The Asia Pacific is the fastest growing febrile seizures market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us
Market Research Future
Maharashtra, India
+1 646 845 9312
Email: sales@Marketresearchfuture.Com

This release was published on openPR.